Company intelligence / Profile preview

Delekang

Xianju, Zhejiang, Chinadelekang.com ↗
Ownership
Private
Employees
~600
Development stage
Other
01

Overview

Zhejiang Delekang Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in the development and large-scale production of active pharmaceutical ingredients (APIs) and natural plant extracts. Founded in 1993 and headquartered in Zhejiang Province, the company has established itself as a premier global supplier of Gabapentin and Pregabalin, holding significant market shares in the United States, Europe, and Asia. Delekang operates state-of-the-art manufacturing facilities that comply with international quality standards, including US FDA, EU GMP, and PMDA certifications. In addition to its core synthetic API portfolio, the company is a major producer of standardized Ginkgo Biloba extracts used in various therapeutic and nutraceutical applications. As a vertically integrated manufacturer, Delekang provides comprehensive CDMO services and maintains a robust export business, supporting global pharmaceutical supply chains for neurological and psychiatric treatments.

Therapeutic areas
RheumatologyPsychiatryNeurology
Modalities
Small moleculeHerbal extract
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on Delekang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delekang.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call